Alan S Forman
CIK 1309439 · last filed 2026-05-01
Alan S Forman is a corporate insider who has filed 19 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for JBGS, was dated May 1, 2026. Across all open-market trades the lifetime net is +$141.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $58.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$58.9K
2
19
$141.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JBGS | Director | 4,000 | $14.72 | $58.9K | $121.6K | 11 | 2026-05-01 |
| STEMLINE THERAPEUTICS INC (STML) Delisted | Director | 0 | — | — | $20.0K | 8 | 2020-06-10 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-01 | JBGS | Grant (A) | — | $0 | EDGAR |
| 2025-04-28 | JBGS | Grant (A) | — | $0 | EDGAR |
| 2024-04-29 | JBGS | Grant (A) | — | $0 | EDGAR |
| 2023-05-05 | JBGS | Grant (A) | — | $0 | EDGAR |
| 2022-05-11 | JBGS | Buy (P) | +5,000 | $121.6K | EDGAR |
| 2022-05-03 | JBGS | Grant (A) | — | $0 | EDGAR |
| 2021-05-03 | JBGS | Grant (A) | — | $0 | EDGAR |
| 2020-06-10 | STEMLINE THERAPEUTICS INC (STML) Delisted | Mixed | −88,298 | $0 | EDGAR |
| 2020-05-04 | JBGS | Grant (A) | — | $0 | EDGAR |
| 2019-12-06 | STEMLINE THERAPEUTICS INC (STML) Delisted | Buy (P) | +1,000 | $9.7K | EDGAR |